Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07397325
PHASE1/PHASE2
Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia
Sponsor: Applied Biology, Inc.
View on ClinicalTrials.gov
Summary
Clinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-04-16
Completion Date
2026-12-07
Last Updated
2026-04-09
Healthy Volunteers
No
Interventions
DRUG
DA-020
7mL application of DA-020 (Topical Oxymetazoline)
DRUG
Placebo
Topical placebo solution
DRUG
DA-020 and Hyperforin
7mL application of DA-020 (Topical Oxymetazoline) and Hyperforin (1.5%)
Locations (2)
Hospital Samel
Manaus, Brazil
University of Rome ("G. Marconi")
Rome, Italy